We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Advanced Melanoma

Journal Scan / Research · May 10, 2021

Novel Therapy in Patients With Metastatic Melanoma of Unknown Primary

Cancer Immunology, Immunotherapy: CII


Additional Info

Cancer Immunology, Immunotherapy: CII
Clinical Outcome of Patients With Metastatic Melanoma of Unknown Primary in the Era of Novel Therapy
Cancer Immunol. Immunother. 2021 Mar 27;[EPub Ahead of Print], D Verver, DJ Grünhagen, ACJ van Akkooi, MJB Aarts, FWPJ van den Berkmortel, AJM van den Eertwegh, JWB de Groot, MJ Boers-Sonderen, JBAG Haanen, GAP Hospers, E Kapiteijn, D Piersma, RS van Rijn, KPM Suijkerbuijk, AJT Tije, G Vreugdenhil, C Verhoef, AAM van der Veldt

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading